Biohaven BHVN Q1 2026 Earnings Miss Sparks Concern Natures NATR Q1 2026 Earnings Beat Revenue NA EPS 030 Advance Auto AAP Q4 2025 Earnings Why the Beat Matters Fed Chair Powell Vows Not to Be Shadow Chair as Warsh Clash Looms at Upcoming Meeting Stocks Surge Oil and Dollar Retreat Amid Renewed Middle East Peace Hopes CD Rates Reach Up to 417 APY as of May 25 2026 Oil Prices Decline Amid Renewed Prospects for USIran Nuclear Agreement Bessent Predicts Substantial Disinflation as Warsh Assumes Fed Leadership Nvidia AMD Broadcom A Comparative Outlook in the Semiconductor Landscape Traders Bet on IonQ and Anduril as Next Potential US Government Equity Targets NEWTI Q1 2026 Earnings EPS Misses Expectations Amid Flat Revenue FRSX Q3 2021 Earnings NarrowerThanExpected Loss Drives Positive Market Response CNH Industrial Q1 2026 Earnings Modest EPS Beat Fails to Lift Sentiment INSM Q1 2026 Earnings EPS Beat of 2234 But Stock Declines 3 VEON Q1 2026 Earnings Earnings Beat Expectations Despite Lack of Revenue Disclosure Rush Street Interactive RSI Q1 2026 Earnings EPS Beats Estimates by 165 Stock Declines Slightly Jade Biosciences JBIO Falters in MidSession Trading Support Levels in Focus Planet Green Holdings PLAG Slides 3 as Shares Test Critical Support at 150 MDxHealth MDXH Slides 625 as Cancer Diagnostics Stock Tests Key Support Level SiNtx Technologies SINT Attempts Recovery Faces Key Test at 247 Resistance Liberty Broadband Preferred Stock LBRDP Slips 129 as Interest Rate Sensitivity Weighs on Yield Plays Salesforce CRM Edges Lower Consolidation Amid Sector Rotation Essent Group ESNT Retreats From Resistance Key Support Levels in Focus Gores Holdings X Inc Warrants GTENW Hold Steady at 065 Key Levels in Focus Eagle Point Credit Notes ECCW Steady Near Par as FixedIncome Market Consolidates Ferrari RACE Shares Dip Nearly 6 as Luxury Sector Faces Headwinds Sempra SRE Edges Lower as Utility Sector Faces Headwinds BP Board Ousts Chair Albert Manifold Amid Unspecified Claims PDS Biotechnology Q1 2026 Earnings Narrowed Loss Per Share and Clinical Progress Drive Positive Market Response Turbo Energy TURB Slips 278 as Stock Tests Key Support at 10